The 9th European Antibody Congress
Nov. 11 to Nov. 13, 2013
Starling Geneva Hotel &Conference Center, Geneva, Switzerland
Organized by Terrapinn, the tree days’ event brings the monoclonal antibody (mAb) and next generation technology industry together. The conference will focus on mAb research and development, including antibody engineering, screening, stability and affinity, mAb production and manufacture, such as increased manufacturing yield and efficiency, maximized antibody titers and improved product recovery methods, antibody expression and purification, antibody drug conjugates and so many other related topics.
The 9th European Antibody Congress 2013 is dedicated to global antibodies market, Antibody innovation, Antibody alternatives and advances, developmental success, antibody therapy approaches and Structure/Function Relationships
Article Link: The 9th European Antibody CongressTags: Antibody Congress, Monoclonal Antibody, Antibody Engineering